PDL BIOPHARMA INC

CUSIP: 69329YAF1 Class: CONV BD US

Radcliffe Capital Management, L.P.'s Holding History (CIK: 0001218275)

Note: Option positions (PUT/CALL) are excluded.

Q4 2017
Shares 20,913,000 Value ($000) $20,907 Avg Close — Range —
Q3 2017
Shares 19,703,000 Value ($000) $19,738 Avg Close — Range —
Q2 2017
Shares 11,598,000 Value ($000) $11,579 Avg Close — Range —